MedMira Reports Second Quarter Results FY2024

2 years ago

HALIFAX, NS / ACCESSWIRE / April 1, 2024 / MedMira Inc. (MedMira) (TSXV:MIR), reported today on its financial results for…

FSD Pharma Announces Filing of Year-End 2023 Results

2 years ago

TORONTO, ON / ACCESSWIRE / April 1, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical…

GE HealthCare closes MIM Software acquisition, bolstering its portfolio and advancing its precision care strategy

2 years ago

With the addition of MIM Software, GE HealthCare aims to provide clinicians and healthcare systems with increasingly integrated and automated…

Spok(R) Clinches 7th Consecutive Title for Leading Satisfaction in Clinical Communications & Messaging, 2024 Black Book Annual Customer Experience Survey

2 years ago

NEW YORK, NY / ACCESSWIRE / April 1, 2024 / Black Book conducted surveys among thousands of healthcare professionals from…

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

2 years ago

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…

AngioDynamics Announces Settlement of All Patent Litigation with C.R. Bard, Inc.

2 years ago

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in…

Scientific Industries to Host Full Year 2023 Financial Results Investor Call on April 3, 2024

2 years ago

Investor Call to be held at 11:00 AM Eastern TimeBOHEMIA, NY / ACCESSWIRE / April 1, 2024 / Scientific Industries,…

CNS Pharmaceuticals Reports Full Year 2023 Financial Results and Highlights Recent Corporate and Clinical Achievements

2 years ago

Lead program, Berubicin, successfully passed pre-planned interim futility analysis milestone with recommendation from DSMB to proceed without modification in potentially…

Protagenic Therapeutics Reports Fourth Quarter and Full Year 2023 Results

2 years ago

Transitioned from Pre-Clinical to Clinical Stage company in FY 2023Phase 1/2a trial, designed to assess both healthy volunteers and patients…